Novartis In Line For Ofatumumab MS Approval In June

Will Rival Roche's Ocrevus

 
• By Kevin Grogan
Calendar_June_2020
Date is in the diary for ofatumumab decision • Source: Shutterstock

More from Neurological

More from Therapeutic Category